Welcome to BioPharmaceuticals Australia's website.

This website is currently under construction and some sections may not yet be fully functional. Thank you for your patience.

Through its commercial partnership with DSM Biologics, BPA aims to deliver tailored contract manufacturing solutions to Australian and international biotherapeutic drug developers. BPA is designing and constructing a new, world-class cGMP manufacturing facility which will open in 2013.

In an Australian-first, the Brisbane based facility will be designed to manufacture biologic drugs for preclinical and clinical trials as well as for market. BPA, supported by the Queensland Government, will significantly enhance Australia's ability to produce biopharmaceuticals and to take discoveries from bench to clinic. BPA's vision is to bring Australia to the forefront of biopharmaceutical development, scale-up and production by providing quality facilities and expertise in conjunction with our commercial operating partner DSM Biologics.

To find out how this initiative can assist you in bringing your biopharmaceutical products to market, take a look at the About Us section and our Partners pages.